Product
Berubicin
Aliases
Berubicin Hydrochloride, berubicin hydrochloride (RTA 744)
Name
Berubicin
3 clinical trials
3 indications
Indication
Brain MetastasesIndication
Glioblastoma MultiformeIndication
High-Grade GliomaClinical trial
A Phase II Efficacy and Tolerability Study of RTA 744 in Breast Cancer Patients With Progression of Previously Irradiated Brain MetastasesStatus: Terminated, Estimated PCD: 2008-12-01
Clinical trial
A Multicenter, Open-Label Study of the Efficacy, Safety, and Pharmacokinetics of Intravenously Infused Berubicin in Adult Patients With Recurrent Glioblastoma Multiforme (WHO Grade IV) After Failure of Standard First Line TherapyStatus: Recruiting, Estimated PCD: 2025-10-31
Clinical trial
A Phase 1, Multicenter, Open-label, Dose Escalation Study of the Safety and Pharmacokinetics of Intravenously Infused Berubicin in Pediatric Patients With Progressive, Refractory, or Recurrent High Grade GliomasStatus: Not yet recruiting, Estimated PCD: 2025-12-01